Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
US Ambassador Adler visits Belgian Volition PR Newswire - Wed Oct 18, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler, U.S....

VNRX : 0.8099 (+10.04%)
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarising key themes from...

VNRX : 0.8099 (+10.04%)
Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison...

VNRX : 0.8099 (+10.04%)
Volition Hosts Key Opinion Leader Roundtable on Sepsis Management PR Newswire - Wed Sep 13, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a Key Opinion Leader ("KOL") roundtable...

VNRX : 0.8099 (+10.04%)
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June...

VNRX : 0.8099 (+10.04%)
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, August 15 at 8.30 a.m. Eastern...

VNRX : 0.8099 (+10.04%)
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters PR Newswire - Fri Jun 23, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that the underwriters of its...

VNRX : 0.8099 (+10.04%)
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock PR Newswire - Mon Jun 5, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today the closing of its previously...

VNRX : 0.8099 (+10.04%)
VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock PR Newswire - Thu Jun 1, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an...

VNRX : 0.8099 (+10.04%)
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock PR Newswire - Wed May 31, 2023

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has...

VNRX : 0.8099 (+10.04%)

Barchart Exclusives

1 Dividend Aristocrat to Buy for Double-Digit Earnings Growth Barchart - Thu May 9, 6:30PM CDT
Discover why Ecolab's recent earnings beat, along with its robust dividend history, make it a standout choice for investors seeking a blend of growth and stability in 2024. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot